Cocaine perturbs mitovesicle biology in the brain.
J Extracell Vesicles.
2023 Jan;12(1):e12301. doi: 10.1002/jev2.12301. PubMed PMID:
36691887; PubMed Central PMCID:
PMC9871795.
Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration.
Nat Commun.
2022 Sep 21;13(1):5308. doi: 10.1038/s41467-022-32944-3. PubMed PMID:
36130946; PubMed Central PMCID:
PMC9492778.
Faulty autolysosome acidification in Alzheimer's disease mouse models induces autophagic build-up of Aβ in neurons, yielding senile plaques.
Nat Neurosci.
2022 Jun;25(6):688-701. doi: 10.1038/s41593-022-01084-8. Epub 2022 Jun 2. PubMed PMID:
35654956; PubMed Central PMCID:
PMC9174056.
Mitovesicles are a novel population of extracellular vesicles of mitochondrial origin altered in Down syndrome.
Sci Adv.
2021 Feb;7(7). doi: 10.1126/sciadv.abe5085. Print 2021 Feb. PubMed PMID:
33579698; PubMed Central PMCID:
PMC7880603.
Endosomal Dysfunction Induced by Directly Overactivating Rab5 Recapitulates Prodromal and Neurodegenerative Features of Alzheimer's Disease.
Cell Rep.
2020 Nov 24;33(8):108420. doi: 10.1016/j.celrep.2020.108420. PubMed PMID:
33238112; PubMed Central PMCID:
PMC7714675.
A pleiotropic role for exosomes loaded with the amyloid β precursor protein carboxyl-terminal fragments in the brain of Down syndrome patients.
Neurobiol Aging.
2019 Dec;84:26-32. doi: 10.1016/j.neurobiolaging.2019.07.016. Epub 2019 Aug 1. PubMed PMID:
31479861; PubMed Central PMCID:
PMC6960325.
Enhanced generation of intraluminal vesicles in neuronal late endosomes in the brain of a Down syndrome mouse model with endosomal dysfunction.
Dev Neurobiol.
2019 Jul;79(7):656-663. doi: 10.1002/dneu.22708. Epub 2019 Aug 1. PubMed PMID:
31278881; PubMed Central PMCID:
PMC6894426.
Neuroprotection mediated by cystatin C-loaded extracellular vesicles.
Sci Rep.
2019 Jul 31;9(1):11104. doi: 10.1038/s41598-019-47524-7. PubMed PMID:
31367000; PubMed Central PMCID:
PMC6668451.
Cystatin C prevents neuronal loss and behavioral deficits via the endosomal pathway in a mouse model of down syndrome.
Neurobiol Dis.
2018 Dec;120:165-173. doi: 10.1016/j.nbd.2018.08.025. Epub 2018 Sep 1. PubMed PMID:
30176349; PubMed Central PMCID:
PMC6309243.
Enhanced exosome secretion in Down syndrome brain - a protective mechanism to alleviate neuronal endosomal abnormalities.
Acta Neuropathol Commun.
2017 Aug 29;5(1):65. doi: 10.1186/s40478-017-0466-0. PubMed PMID:
28851452; PubMed Central PMCID:
PMC5576289.
Lysosomal dysfunction in the brain of a mouse model with intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein.
Mol Psychiatry.
2017 Jul;22(7):981-989. doi: 10.1038/mp.2016.189. Epub 2016 Oct 25. PubMed PMID:
27777419; PubMed Central PMCID:
PMC5405008.
Cyclodextrin has conflicting actions on autophagy flux in vivo in brains of normal and Alzheimer model mice.
Hum Mol Genet.
2017 Mar 1;26(5):843-859. doi: 10.1093/hmg/ddx001. PubMed PMID:
28062666; PubMed Central PMCID:
PMC6075207.
Autophagy dysfunction and regulatory cystatin C in macrophage death of atherosclerosis.
J Cell Mol Med.
2016 Sep;20(9):1664-72. doi: 10.1111/jcmm.12859. Epub 2016 Apr 14. PubMed PMID:
27079462; PubMed Central PMCID:
PMC4988293.
Partial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: role of APP-CTF.
Neurobiol Aging.
2016 Mar;39:90-8. doi: 10.1016/j.neurobiolaging.2015.11.013. Epub 2015 Dec 2. PubMed PMID:
26923405; PubMed Central PMCID:
PMC4773919.
Defective macroautophagic turnover of brain lipids in the TgCRND8 Alzheimer mouse model: prevention by correcting lysosomal proteolytic deficits.
Brain.
2014 Dec;137(Pt 12):3300-18. doi: 10.1093/brain/awu278. Epub 2014 Sep 29. PubMed PMID:
25270989; PubMed Central PMCID:
PMC4240291.
Glutamatergic transmission aberration: a major cause of behavioral deficits in a murine model of Down's syndrome.
J Neurosci.
2014 Apr 9;34(15):5099-106. doi: 10.1523/JNEUROSCI.5338-13.2014. PubMed PMID:
24719089; PubMed Central PMCID:
PMC3983795.
Therapeutic effects of remediating autophagy failure in a mouse model of Alzheimer disease by enhancing lysosomal proteolysis.
Autophagy.
2011 Jul;7(7):788-9. doi: 10.4161/auto.7.7.15596. Epub 2011 Jul 1. PubMed PMID:
21464620; PubMed Central PMCID:
PMC3359468.
Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits.
Brain.
2011 Jan;134(Pt 1):258-77. doi: 10.1093/brain/awq341. PubMed PMID:
21186265; PubMed Central PMCID:
PMC3009842.
Cystatin C rescues degenerating neurons in a cystatin B-knockout mouse model of progressive myoclonus epilepsy.
Am J Pathol.
2010 Nov;177(5):2256-67. doi: 10.2353/ajpath.2010.100461. Epub 2010 Oct 1. PubMed PMID:
20889561; PubMed Central PMCID:
PMC2966785.
Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines.
PLoS One.
2010 Mar 23;5(3):e9819. doi: 10.1371/journal.pone.0009819. PubMed PMID:
20352108; PubMed Central PMCID:
PMC2843718.
Neuronal apoptosis and autophagy cross talk in aging PS/APP mice, a model of Alzheimer's disease.
Am J Pathol.
2008 Sep;173(3):665-81. doi: 10.2353/ajpath.2008.071176. Epub 2008 Aug 7. PubMed PMID:
18688038; PubMed Central PMCID:
PMC2527090.
Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models.
Nat Genet.
2007 Dec;39(12):1440-2. doi: 10.1038/ng.2007.29. Epub 2007 Nov 18. PubMed PMID:
18026100.
Proteins that bind to the RERMS region of beta amyloid precursor protein.
Biochem Biophys Res Commun.
2007 Apr 20;355(4):907-12. doi: 10.1016/j.bbrc.2007.02.047. Epub 2007 Feb 20. PubMed PMID:
17335780; PubMed Central PMCID:
PMC1896148.
Purification of human wild-type or variant cystatin C from conditioned media of transfected cells.
Methods Mol Biol.
2005;299:221-6. doi: 10.1385/1-59259-874-9:221. PubMed PMID:
15980605.
Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation.
Neurobiol Aging.
2004 Sep;25(8):1033-43. doi: 10.1016/j.neurobiolaging.2003.11.006. PubMed PMID:
15212828.
Overexpression of human cystatin C in transgenic mice does not affect levels of endogenous brain amyloid Beta Peptide.
J Mol Neurosci.
2004;22(1-2):13-8. doi: 10.1385/JMN:22:1-2:13. PubMed PMID:
14742906.
Distinct properties of wild-type and the amyloidogenic human cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type.
J Neurochem.
2001 Apr;77(2):628-37. doi: 10.1046/j.1471-4159.2001.00256.x. PubMed PMID:
11299325.
Primate-like amyloid-beta sequence but no cerebral amyloidosis in aged tree shrews.
Neurobiol Aging.
1999 Jan-Feb;20(1):47-51. doi: 10.1016/s0197-4580(99)00017-2. PubMed PMID:
10466892.
Induction of Signal Transducing Pathways by SPP binding to the Cell Surface Receptor.
In:
Iqbak K, Mortimer J, Weinblad B, Wisniewski H, editors.
Research Advances in Alzheimer's Disease and Related Disorders
New York: Wiley; 1995. p.693 - 699.
[3H]harman binding experiments. II: Regional and subcellular distribution of specific [3H]harman binding and monoamine oxidase subtypes A and B activity in marmoset and rat.
J Neurochem.
1991 Feb;56(2):500-8. doi: 10.1111/j.1471-4159.1991.tb08178.x. PubMed PMID:
1988553.
[3H]harman binding experiments. I: A reversible and selective radioligand for monoamine oxidase subtype A in the CNS of the rat.
J Neurochem.
1991 Feb;56(2):490-9. doi: 10.1111/j.1471-4159.1991.tb08177.x. PubMed PMID:
1988552.
Quantitative autoradiography of [3H]norharman [( 3H]beta-carboline) binding sites in the rat brain.
J Chem Neuroanat.
1990 Jan-Feb;3(1):19-24. PubMed PMID:
2156525.
Demonstration of a distinct class of high-affinity binding sites for [3H]norharman [( 3H]beta-carboline) in the rat brain.
Eur J Pharmacol.
1988 Mar 1;147(2):163-71. doi: 10.1016/0014-2999(88)90775-3. PubMed PMID:
3366173.
What would you like to do?